Everest Medicines Limited (HKG:1952)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
58.45
+1.65 (2.90%)
Apr 3, 2025, 4:08 PM HKT

Everest Medicines Revenue

In the year 2024, Everest Medicines had annual revenue of 706.68M CNY with 461.16% growth. Everest Medicines had revenue of 405.16M in the half year ending December 31, 2024, with 3,348.77% growth.

Revenue
706.68M CNY
Revenue Growth
+461.16%
P/S Ratio
24.94
Revenue / Employee
1.06M CNY
Employees
665
Market Cap
18.96B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024706.68M580.75M461.16%
Dec 31, 2023125.93M113.14M884.46%
Dec 31, 202212.79M12.74M23,588.89%
Dec 31, 202154.00K--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition